A first in class, mechanism-guided, cell-based therapy for complex regional pain syndrome — JIANGUO CHENG (CLEVELAND CLINIC LERNER
Chronic pain afflicts more than 50 million American adults and costs our nation an estimated $560 to $635 billion annually. Complex regional pain syndrome (CRPS) represents one of the most disabling a
| Project title | A first in class, mechanism-guided, cell-based therapy for complex regional pain syndrome |
|---|---|
| Project number | 1UG3NS127258-01A1 |
| PI name | JIANGUO CHENG |
| Institution | CLEVELAND CLINIC LERNER COM-CWRU |
| Funding mechanism | UG3 |
| Agency | NINDS |
| Award amount | $2.03M |
| Fiscal year | 2022 |
| Project start | 2022-09-24T00:00:00 |
| Project end | 2025-08-31T00:00:00 |
| Abstract | Chronic pain afflicts more than 50 million American adults and costs our nation an estimated $560 to $635 billion annually. Complex regional pain syndrome (CRPS) represents one of the most disabling a |
| Key terms | <21+ years old><7S Gamma Globulin><Address><Adipose tissue><Adult><Adult Human><American><Analgesic |
$799/mo
Try GrantRadar →